Nilotinib label updated with info on discontinuationDecember 23, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
FDA expands approved use of bosutinib in CMLDecember 20, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Health Canada approves midostaurin for AMLDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
Companies launch generic busulfan in USDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Drug receives fast track designation for FLT3+ rel/ref AMLDecember 2, 2017Leukemia, Myelodysplasia, TransplantationPharmacyAML
FDA grants priority review to NDA for avatrombopagNovember 29, 2017AnemiaThrombosisPharmacyBleeding Disorders
Nilotinib approved to treat kids with CML in EUNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Product approved to treat patients with hemophilia A and inhibitorsNovember 17, 2017ThrombosisPharmacyBleeding Disorders
FDA approves generic clofarabineNovember 16, 2017Leukemia, Myelodysplasia, TransplantationPharmacyALL
Generic azacitidine approved in CanadaNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome